Article

Test could aid detection of AMD

According to a Canadian study, computer-based methods for evaluating the eye's ability to distinguish object details and shape in patients with age-related macular degeneration (AMD) could provide a more accurate assessment of the effectiveness of eye surgery and vision rehabilitation.

According to a Canadian study, computer-based methods for evaluating the eye's ability to distinguish object details and shape in patients with age-related macular degeneration (AMD) could provide a more accurate assessment of the effectiveness of eye surgery and vision rehabilitation.

Authors of the study incorporated four known features to improve visual acuity in their computer-based method: high contrast; white optotypes (symbols, letters, or numbers used in vision testing) on a black background to reduce intraocular scatter; proportional layout to reduce the effect of crowding; and multiple optotypes to minimize the effects of fixation instability and to maximize the likelihood of optotype detection.

After experimenting authors concluded that a multiple-optotype, reversed-polarity test is most effective in estimating a patient's optimal visual acuity at baseline before vision rehabilitation interventions or surgery.

"People with AMD rarely read or view things under optimal conditions, so this is not a test of how well they see in daily life," said study author, Esther G. González "This test is designed to give vision rehabilitation practitioners a measure of the best visual acuity a person is capable of and in this sense it could be a useful tool for assessing rehabilitation progress."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.